Mechanistic studies have shown that there exists a molecular interplay between lipid dysmetabolism and inflammatory pathways in inducing hepcidin expression in NAFLD (Lu et al. 2016). The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.